A Randomized, Double-Blind, Placebo-Controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple-Doses of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) Patients

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

Brain Imaging Center (BIC)
CTRC Inpatient
Outpatient CTRC
University of Colorado Hospital

Study ID

Protocol Number: 21-3032

More information available at ClinicalTrials.gov: NCT05027269

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers